Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.7 |
mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.06 | 0.7 |
mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.7 |
mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.061 | 0.7 |
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |